[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351280-105":59,"doc-detail-351280-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","emerging-salivary-exosome-nanodiagnostics-for-early-oral-squamous-cell-carcinoma-platforms-biomarkers-and-future-perspectives","Emerging Salivary Exosome Nanodiagnostics for Early Oral Squamous Cell Carcinoma - Platforms, Biomarkers, and Future Perspectives","","Early oral squamous cell carcinoma (OSCC) is often missed because conventional imaging and biopsy cannot detect subtle preclinical molecular changes. Salivary exosome nanodiagnostics seeks to transform a proximal, information-rich nanoscale biospecimen into quantitative, repeatable readouts for screening and longitudinal monitoring. Clinical translation is limited by saliva pre-analytical variability, yield–purity losses, low-abundance tumor signals, and biomarker heterogeneity. This work integrates salivary exosomal biomarker landscapes and proposes nanotechnology-enabled enrichment, signal-amplification circuits, and optical/electrochemical readouts, with a unifying co-design framework and translational roadmap.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-salivary-exosome-nanodiagnostics-for-early-oral-squamous-cell-carcinoma-platforms-biomarkers-and-future-perspectives/351280/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-salivary-exosome-nanodiagnostics-for-early-oral-squamous-cell-carcinoma-platforms-biomarkers-and-future-perspectives/351280.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is early oral squamous cell carcinoma difficult to detect with conventional methods?","Question",{"text":113,"@type":114},"Conventional imaging and biopsy poorly detect subtle, preclinical molecular changes, so diagnosis is often delayed to later stages.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What four bottlenecks constrain clinical translation of salivary exosome nanodiagnostics?",{"text":118,"@type":114},"They include pre-analytical variability in saliva collection/processing/storage, yield–purity trade-offs during vesicle enrichment, low-abundance tumor signals masked by abundant background vesicles, and biomarker heterogeneity across cohorts.",{"name":120,"@type":111,"acceptedAnswer":121},"How do the proposed nanotechnology solutions improve exosome-based OSCC detection?",{"text":122,"@type":114},"The approach combines enrichment strategies, nucleic-acid amplification circuits for signal gain, and optical or electrochemical transduction methods compatible with small sample volumes, while using multi-marker panels with analytical benchmarks.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351280,1790907619,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","International Journal of Nanomedicine  \n Open Access Full Text Article  \nREVIEW  \nEmerging Salivary Exosome Nanodiagnostics for Early Oral Squamous Cell Carcinoma: Platforms, Biomarkers, and Future Perspectives  \nLai-Xi Zhao 1 , *, En-Tang Wang2 , *, Wen-Hao Jia 1 , Mo-Han Wang 5 , Zhao Pan4 , Liang Dong4 , Hui-Qin Wen 3 , Wen-Hua Xu 1 , Rui Xu 1  \n1College & Hospital of Stomatology, Anhui Medical University, Anhui Province Key Laboratory of Oral Diseases Research, Hefei, 230032, People’s Republic of China; 2Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, People’s Republic of China; 3Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of China; 4Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, People’s Republic of China; 5Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Rui Xu; Wen-Hua Xu, Email [dentistxr@126.com](dentistxr@126.com); [xuwenhua@ahmu.edu.cn](xuwenhua@ahmu.edu.cn)  \n\n| Abstract: Early oral squamous cell carcinoma (OSCC) is frequently missed because conventional imaging and biopsy are poorly suited to detect subtle, preclinical molecular changes. Emerging salivary exosome nanodiagnostics aims to convert an anatomically proximal, information-rich nanoscale biospecimen into quantitative and repeatable readouts for screening and longitudinal monitoring. Clinical translation, however, is constrained by four bottlenecks: (i) pre-analytical variability in saliva collection, processing, and storage; (ii) yield–purity trade-offs during vesicle enrichment; (iii) low-abundance tumor-derived signals masked by abundant background vesicles; and (iv) biomarker heterogeneity that limits robustness across cohorts. Here, we integrate the landscape of salivary exosomal biomarkers (nucleic acids, proteins, and other cargo) and synthesize nanotechnology-enabled solutions that directly address these barriers, including microfluidic and affinity-based enrichment, nucleic-acid amplification circuits (eg, RCA, HCR, CHA) for signal gain, and optical/electrochemical transduction (eg, SPR, SERS) compatible with microliter-scale samples. Beyond listing platforms, we propose a unifying framework: co-design capture and readout to preserve biological specificity, match biomarker modality to detection physics, and prioritize multi-marker panels with transparent analytical benchmarks. Finally, we outline a translational roadmap spanning standardization, reproducibility, prospective multicenter validation, manufacturability, and regulatory readiness to accelerate clinically actionable early OSCC detection.\u003Cbr>Keywords: oral squamous cell carcinoma, salivary exosomes, exosomal biomarkers, liquid biopsy, nanodiagnostics, nanoplatform |\n| --- |\n| Introduction\u003Cbr>Oral squamous cell carcinoma (OSCC) is the most common subtype of head and neck squamous cell carcinoma (HNSCC), primarily affecting the mucosa of the tongue, buccal cavity, gingiva, palate, and floor of the mouth.1 According to recent global statistics, approximately 389,485 new cases of lip and oral cavity cancer were diagnosed, and188230related deaths occurred in 2022.2 Despite significant advances in therapeutic interventions, the survival rate and quality of life for OSCC patients remain suboptimal.3,4 This can largely be attributed to the high rates of recurrence and distant metastasis associated with the disease.5,6 Furthermore, the 5-yea","cbCaidaE5yoXzvnC","https://ap.wps.com/l/cbCaidaE5yoXzvnC","pdf",5982461,"English","# Abstract\n# Introduction","[{\"question\":\"Why is early oral squamous cell carcinoma difficult to detect with conventional methods?\",\"answer\":\"Conventional imaging and biopsy poorly detect subtle, preclinical molecular changes, so diagnosis is often delayed to later stages.\"},{\"question\":\"What four bottlenecks constrain clinical translation of salivary exosome nanodiagnostics?\",\"answer\":\"They include pre-analytical variability in saliva collection/processing/storage, yield–purity trade-offs during vesicle enrichment, low-abundance tumor signals masked by abundant background vesicles, and biomarker heterogeneity across cohorts.\"},{\"question\":\"How do the proposed nanotechnology solutions improve exosome-based OSCC detection?\",\"answer\":\"The approach combines enrichment strategies, nucleic-acid amplification circuits for signal gain, and optical or electrochemical transduction methods compatible with small sample volumes, while using multi-marker panels with analytical benchmarks.\"}]","Emerging Salivary Exosome Nanodiagnostics for Early Oral Squamous Cell Carcinoma - Platforms, Biomarkers, and Future Perspectives | PDF",1790093363,76,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4b9e73d79e2d913315ba65ce9a8eda8.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2680c835221ee0ddc7b7cbc2e6bdead7.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d42406f5d79a969378c5a00346ca1dfb.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c49f75eb248c7048f1e42f8e7f23686a.webp",980,1268]